Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding CANC?
Track your performance easily
CANC Price & Analysis
CANC ETF Chart & Stats
Day’s Range― - ―
52-Week Range$22.90 - $30.11
Previous Close$26.52
VolumeN/A
Average Volume (3M)3.02K
AUM45.72M
NAV26.48
Expense Ratio0.75%
Holdings Count51
Beta1.17
Inception DateAug 15, 2023
Last Dividend Ex-Date
Dec 13, 2023Dividend Yield
0.15 (0.57%)Shares Outstanding1,740,000
Standard Deviation0.06
10 Day Avg. Volume3,027
30 Day Avg. Volume3,017
Alpha-0.01
Tema Oncology ETF (CANC) Fund Flow Chart
Tema Oncology ETF (CANC) 1 year Net Flows: $29M
CANC ETF News
CANC ETF FAQ
What was CANC’s price range in the past 12 months?
CANC lowest ETF price was $22.90 and its highest was $30.11 in the past 12 months.
What is the AUM of CANC?
As of Nov 21, 2024 The AUM of CANC is 45.72M.
Is CANC overvalued?
According to Wall Street analysts CANC’s price is currently Undervalued.
Does CANC pay dividends?
CANC pays a Notavailable dividend of $0.15 which represents an annual dividend yield of 0.57%. See more information on CANC dividends here
How many shares outstanding does CANC have?
CANC has 1,740,000 shares outstanding.
Which hedge fund is a major shareholder of CANC?
Currently, no hedge funds are holding shares in CANC
CANC ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Gilead Sciences
5.44%
Regeneron Pharmaceuticals
5.20%
AstraZeneca plc
5.19%
Revolution Medicines, Inc.
4.71%
Argenx
4.21%
Blueprint Medicines Corp.
4.17%
Illumina
4.11%
Incyte
3.87%
Chugai Pharmaceutical Co
3.35%
Daiichi Sankyo Company
3.09%
Total43.34%
ETF Description
Tema Oncology ETF
CANC is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations.